Investor After-work Q&A

Will there be any young investors meetings irl?

There is a trend of new molecules emerging in obesity treatment, such as amylin. Could yours be something new?

What price does Pila need to reach for a sale to be attractive?

What could be the value for shareholders if you achieve more positive cardiovascular results?

What trends do you see (subjectively) that support Pila in the obesity market?

How are you different from Zealand Pharma?

How are you different from Gubra? You had a strong upturn when their stock took a hit this summer.

Why don't you release announcements in Swedish?

What is the status of the preclinical cardiovascular collaboration announced last year?

What is the status of your orphan plan?

Does the U.S. election have any impact on Pila's processes?

Does Pila have other products in the pipeline if the next trial has a negative outcome?

When might the next share issuance be expected—has this been planned yet?

Is there a lock-up period for investors who participated in the private placement this summer?

Is Pila currently in dialogue with any specific Big Pharma companies?

Where will the next roadshow be held? Are there places and times where one can register?

Many new investors have joined on the Nordnet platform —doubling over the last 5-6 months. Is Pila actively doing anything to expand its reach, and if so, what specifically?

Is the funding from the 12-15 investors enough to finance Pila until results are achieved?

When does Pila expect the first human trials to begin?

When can we expect results from Phase 2a

Does the Pila Pharma pill have a positive effect on weight reduction?